Sanofi to Soon Start Testing Potential Zika Vaccines on Animals

  • Animal tests to help drugmaker select promising candidates
  • Company in active talks for possible Zika partnerships

Sanofi will begin testing potential Zika vaccines on animals this quarter, a step forward in the French drugmaker’s plans to select the most promising approaches, and start tests on humans next year.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.